CASI Pharmaceuticals
CASI
#9475
Rank
A$70.92 M
Marketcap
$4.59
Share price
-5.30%
Change (1 day)
-54.51%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$44.32 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$22.05 Million. In 2023 the company made an earning of -A$42.31 Million, an increase over its 2022 earnings that were of -A$60.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.32 Million4.76%
2023 -A$42.31 Million-29.55%
2022 -A$60.04 Million4.43%
2021 -A$57.5 Million-24.56%
2020 -A$76.21 Million4.74%
2019 -A$72.77 Million65.13%
2018 -A$44.07 Million155.07%
2017 -A$17.28 Million13.93%
2016 -A$15.17 Million31.18%
2015 -A$11.56 Million-72.5%
2014 -A$42.03 Million356.62%
2013 -A$9.21 Million-60.55%
2012 -A$23.34 Million218.41%
2011 -A$7.33 Million0.74%
2010 -A$7.28 Million-32.54%
2009 -A$10.79 Million-66.98%
2008 -A$32.66 Million-14.22%
2007 -A$38.07 Million7.04%
2006 -A$35.57 Million27.95%
2005 -A$27.8 Million4.51%
2004 -A$26.6 Million-15.84%
2003 -A$31.6 Million-55.29%
2002 -A$70.68 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$81.36 Million31.56%
1999 -A$61.84 Million145.56%
1998 -A$25.19 Million76.4%
1997 -A$14.28 Million36.92%
1996 -A$10.43 Million